AI is fundamentally realigning the healthcare and fintech economies by moving beyond theoretical applications to tangible, high-impact products. In healthcare, AI-driven tools are revolutionizing drug discovery and clinical workflows, significantly reducing the high failure rates and administrative burdens that have long plagued the industry. Companies like Devoted Health demonstrate this shift, leveraging AI to achieve rapid growth and operational efficiency. While the U.S. faces existential threats in life sciences from global competitors, technological advancements in simulation and robotics offer a path to accelerate drug development and improve patient outcomes. Successful investment in this era demands a focus on founders with deep domain expertise who can build defensible, horizontal platforms. This evolution in the investment landscape emphasizes the necessity of rigorous diligence and the ability to distinguish between genuine, scalable innovation and temporary market hype.
Sign in to continue reading, translating and more.
Open full episode in Podwise